Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy and ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and ...

A study found Indian generics sold in the US between 2009-2018 linked to a 54% higher risk of serious side effects compared ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by ...

Dehradun: An Indian pharmaceutical firm, whose products Singapore's Health Sciences Authority (HSA) allegedly issued images ...

India has a strong pharma network, with more than 10,000 manufacturing facilities, over 3,000 pharma companies.

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian ...

The USFDA has established an office in India to oversee the number of Indian manufacturers qualified to supply generic ...

The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from ...

Exporters can pass on cost increases to consumers, and the favourable USD/INR exchange rate and increased outsourcing ...

The Indian Pharmaceutical Alliance refutes a study claiming Indian generic drugs have higher adverse events, stating quality ...